Trials / Completed
CompletedNCT04278391
Pharmacokinetics and Safety Between "DWJ1421" and "DWC201903" in Healthy Male Volunteers
A Randomized, Open Label, Single Dose, Crossover Study to Compare the Pharmacokinetics and Safety Between "DWJ1421" and "DWC201903" in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Daewoong Pharmaceutical Co. LTD. · Industry
- Sex
- Male
- Age
- 19 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This is a randomized, open label, single dose, crossover study to compare the pharmacokinetics and safety between "DWJ1421" and "DWC201903" in healthy male volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DWJ1421 | 1 tablet administered in fasting condition |
| DRUG | DWC201903 | 1 tablet administered in fasting condition |
Timeline
- Start date
- 2019-07-02
- Primary completion
- 2019-08-10
- Completion
- 2020-02-19
- First posted
- 2020-02-20
- Last updated
- 2020-02-20
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04278391. Inclusion in this directory is not an endorsement.